BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22776657)

  • 1. Identification and expression of a tumor-associated antigen in esophageal squamous cell carcinoma.
    Gao HJ; Yue ZG; Zheng M; Zheng ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):244-8. PubMed ID: 22776657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
    Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
    Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY
    J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
    Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.
    Gao H; Zheng Z; Mao Y; Wang W; Qiao Y; Zhou L; Liu F; He H; Zhao X
    Cancer Lett; 2014 Mar; 344(1):54-61. PubMed ID: 24157810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
    Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
    Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
    Kashyap MK; Harsha HC; Renuse S; Pawar H; Sahasrabuddhe NA; Kim MS; Marimuthu A; Keerthikumar S; Muthusamy B; Kandasamy K; Subbannayya Y; Prasad TS; Mahmood R; Chaerkady R; Meltzer SJ; Kumar RV; Rustgi AK; Pandey A
    Cancer Biol Ther; 2010 Oct; 10(8):796-810. PubMed ID: 20686364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
    Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
    Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas.
    Hu H; Luo ML; Du XL; Feng YB; Zhang Y; Shen XM; Xu X; Cai Y; Han YL; Wang MR
    Chin Med J (Engl); 2007 Dec; 120(23):2092-8. PubMed ID: 18167182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.
    Zhu X; Ding M; Yu ML; Feng MX; Tan LJ; Zhao FK
    BMC Cancer; 2010 Jun; 10():290. PubMed ID: 20546628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion.
    Zhang H; Xu L; Xiao D; Xie J; Zeng H; Wang Z; Zhang X; Niu Y; Shen Z; Shen J; Wu X; Li E
    J Clin Pathol; 2007 May; 60(5):555-61. PubMed ID: 17412867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker Discovery and Verification of Esophageal Squamous Cell Carcinoma Using Integration of SWATH/MRM.
    Hou G; Lou X; Sun Y; Xu S; Zi J; Wang Q; Zhou B; Han B; Wu L; Zhao X; Lin L; Liu S
    J Proteome Res; 2015 Sep; 14(9):3793-803. PubMed ID: 26224564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma.
    Liu WL; Zhang G; Wang JY; Cao JY; Guo XZ; Xu LH; Li MZ; Song LB; Huang WL; Zeng MS
    Biochem Biophys Res Commun; 2008 Oct; 375(3):440-5. PubMed ID: 18722351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
    Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
    Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer.
    Peng XC; Gong FM; Chen Y; Qiu M; Cheng K; Tang J; Ge J; Chen N; Zeng H; Liu JY
    J Proteomics; 2016 Jan; 132():85-92. PubMed ID: 26655504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of SAMD9 expression in esophageal squamous cell carcinoma].
    Tang S; Zheng X; He L; Qiao L; Jing D; Ni Z; Zeng W; Jiang M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Apr; 30(4):411-3. PubMed ID: 24721411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma.
    Ren HZ; Wang JS; Pan GQ; Lv H; Wen JF; Luo GQ; Wang KS; Zhang PF
    Dis Esophagus; 2010 Feb; 23(2):175-84. PubMed ID: 19664078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.